Cargando…

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma

Introduction: Synovial sarcoma (SaSy) is a high-grade, malignant soft tissue sarcoma (STS) accounting for 5–9% of STS. The aim of this study was to analyse outcomes of patients with localised SaSy treated in a single institution with a uniform neo- and adjuvant-combined therapy protocol. Methods: 17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozak, Katarzyna, Teterycz, Paweł, Świtaj, Tomasz, Koseła-Paterczyk, Hanna, Falkowski, Sławomir, Morysiński, Tadeusz, Bartnik, Ewa, Czarnecka, Anna M., Wągrodzki, Michał, Ługowska, Iwona, Rutkowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601566/ https://www.ncbi.nlm.nih.gov/pubmed/32998194 http://dx.doi.org/10.3390/jcm9103129

Ejemplares similares

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021)

Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021)

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019)

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)

Trametinib: a MEK inhibitor for management of metastatic melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015)

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022)

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma
por: Czarnecka, Anna M., et al.
Publicado: (2021)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
por: Przybyl, Joanna, et al.
Publicado: (2014)

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
por: Sobczuk, Paweł, et al.
Publicado: (2022)

67P Detrimental effect of the COVID-19 pandemic on patients with adult extremity bone sarcoma: Reference center experience
por: Teterycz, P., et al.
Publicado: (2023)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective
por: Świtaj, Tomasz, et al.
Publicado: (2021)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021)

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
por: Rutkowski, Piotr, et al.
Publicado: (2015)

Serum markers in early-stage and locally advanced melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015)

Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions
por: Czarnecka, Anna M, et al.
Publicado: (2023)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020)

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma
por: Dawidowska, Anna, et al.
Publicado: (2022)

Solitary fibrous tumour along with non-small-cell lung cancer and Doege-Potter syndrome
por: Piórek, Aleksandra, et al.
Publicado: (2019)

Follow-up in soft tissue sarcomas
por: Rutkowski, Piotr, et al.
Publicado: (2014)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

Age as an independent prognostic factor for survival of localised synovial sarcoma patients
por: Vlenterie, Myrella, et al.
Publicado: (2015)

Signatures of circulating microRNA in four sarcoma subtypes
por: Kosela-Paterczyk, Hanna, et al.
Publicado: (2020)

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
por: Rutkowski, Piotr, et al.
Publicado: (2012)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

Surgery combined with brachytherapy in patients with retroperitoneal sarcomas
por: Dziewirski, Wirginiusz, et al.
Publicado: (2010)

Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

Targeted Therapy in Melanoma and Mechanisms of Resistance
por: Czarnecka, Anna M., et al.
Publicado: (2020)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
por: Placzke, Joanna, et al.
Publicado: (2023)

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
por: Czarnecka, Anna M., et al.
Publicado: (2022)

Molecular Biology of Osteosarcoma
por: Czarnecka, Anna M., et al.
Publicado: (2020)

Follow-up in melanoma patients
por: Rutkowski, Piotr, et al.
Publicado: (2014)

Mutation profile of primary subungual melanomas in Caucasians
por: Borkowska, Aneta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o99df642mu90jeq91ijppghcr1